Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques

Journal of Medical Virology

Volumn 73, Issue 3, 2004, Pages 368-377

  Miyake, Ariko ^a   Akagi, Takami ^b   Enose, Yoshimi ^a,g   Kawamura, Masamichi ^c,h   Horiuchi, Reii ^a   Hiraishi, Katsuya ^b   Adachi, Masakazu ^b   Serizawa, Takeshi ^c   Narayan, Opendra ^d   Akashi, Mitsuru ^c,e,f   Baba, Masanori ^c,f   Hayami, Masanori ^a  

^a KYOTO UNIVERSITY   (Japan)

^b JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

^d UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^e OSAKA UNIVERSITY   (Japan)

^f JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^g UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^h UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Intranasal immunization; Intravaginal challenge; Mucosal immunity; SHIV; Vaccine

Indexed keywords

CONCANAVALIN A; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INACTIVATED VACCINE; NANOPARTICLE; POLYSTYRENE; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS RNA;

ADOLESCENT; ANTIBODY RESPONSE; ARTICLE; CLEARANCE; CONTROLLED STUDY; EXPERIMENTAL INFECTION; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INTRANASAL DRUG ADMINISTRATION; MACACA; MUCOSAL IMMUNITY; NONHUMAN; PROVOCATION TEST; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS KU 2; VAGINA MUCOSA; VIRUS CHALLENGE; VIRUS CLEARANCE; VIRUS IMMUNITY; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS PARTICLE; VIRUS TRANSMISSION;

ADMINISTRATION, INTRANASAL; AIDS VACCINES; ANIMALS; CONCANAVALIN A; FEMALE; GASTROINTESTINAL TRACT; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; IMMUNITY, MUCOSAL; IMMUNOGLOBULINS; MACACA MULATTA; NANOTUBES; PLASMA; POLYSTYRENES; RNA, VIRAL; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VACCINES, INACTIVATED; VAGINA; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; SIMIAE; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 2542505511     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20100     Document Type: Article

References (45)

1. Akagi T, Kawamura M, Ueno M, Hiraishi K, Adachi M, Serizawa T, Akashi M, Baba M. 2003. Mucosal immunization with inactivated HIV-1-capturing nanospheres induces a significant HIV-1-specific vaginal antibody response in mice. J Med Virol 69:163-172.
2. Akahata W, Ido E, Akiyama H, Uesaka H, Enose Y, Horiuchi R, Kuwata T, Goto T, Takahashi H, Hayami M. 2003. DNA vaccination of macaques by a full-genome simian/human immunodeficiency virus type 1 plasmid chimera that produces non-infectious virus particles. J Gen Virol 84:2237-2244.
3. Akashi M, Niikawa T, Serizawa T, Hayakawa T, Baba M. 1998. Capture of HIV-1 gp120 and virions by lectin-immobilized polystyrene nanospheres. Bioconjug Chem 9:50-53.
4. Amara RR, Villinger F, Altman JD, Lydy SL, O'Neil SP, Staprans SI, Montefiori DC, Xu Y, Herndon JG, Wyatt LS, Candido MA, Kozyr NL, Earl PL, Smith JM, Ma HL, Grimm BD, Hulsey ML, Miller J, McClure HM, McNicholl JM, Moss B, Robinson HL. 2001. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292:69-74.
5. Belyakov IM, Hel Z, Kelsall B, Kuznetsov VA, Ahlers JD, Nacsa J, Watkins DI, Allen TM, Sette A, Altman J, Woodward R, Markham PD, Clements JD, Franchini G, Strober W, Berzofsky JA. 2001. Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat Med 7:1320-1326.
6. Bergmeier LA, Mitchell EA, Hall G, Cranage MP, Cook N, Dennis M, Lehner T. 1998. Antibody-secreting cells specific for simian immunodeficiency virus antigens in lymphoid and mucosal tissues of immunized macaques. AIDS 12:1139-1147.
7. Bogers WM, Cheng-Mayer C, Montelaro RC. 2000. Developments in preclinical AIDS vaccine efficacy models. AIDS 14:S141-S151.
8. Buge SL, Richardson E, Alipanah S, Markham P, Cheng S, Kalyan N, Miller CJ, Lubeck M, Udem S, Eldridge J, Robert-Guroff M. 1997. An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge. J Virol 71:8531-8541.
9. Chen X, Scala G, Quinto I, Liu W, Chun TW, Justement JS, Cohen OJ, vanCott TC, Iwanicki M, Lewis MG, Greenhouse J, Barry T, Venzon D, Fauci AS. 2001. Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes. Nat Med 7:1225-1231.
10. Crotty S, Lohman BL, Lu FX, Tang S, Miller CJ, Andino R. 1999. Mucosal immunization of cynomolgus macaques with two serotypes of live poliovirus vectors expressing simian immunodeficiency virus antigens: Stimulation of humoral, mucosal, and cellular immunity. J Virol 73:9485-9895.
11. Enose Y, Ui M, Miyake A, Suzuki H, Uesaka H, Kuwata T, Kunisawa J, Kiyono H, Takahashi H, Miura T, Hayami M. 2002. Protection by intranasal immunization of a nef-deleted, nonpathogenic SHIV against intravaginal challenge with a heterologous pathogenic SHIV. Virology 298:306-316.
12. Hayakawa T, Kawamura M, Okamoto M, Baba M, Niikawa T, Takehara S, Serizawa T, Akashi M. 1998. Concanavalin A-immobilized polystyrene nanospheres capture HIV-1 virions and gp120: Potential approach towards prevention of viral transmission. J Med Virol 56:327-331.
13. Igarashi T, Ami Y, Yamamoto H, Shibata R, Kuwata T, Mukai R, Shinohara K, Komatsu T, Adachi A, Hayami M. 1997. Protection of monkeys vaccinated with vpr- and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: A potential candidate live-attenuated human AIDS vaccine. J Gen Virol 78:985-989.
14. Imaoka K, Miller CJ, Kubota M, MeChesney MB, Lohman B, Yamamoto M, Fujihashi K, Someya K, Honda M, McGhee JR, Kiyono H. 1998. Nasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific immune responses in reproductive tissues. J Immunol 161:5952-5958.
15. + T cells and AIDS in pig-tailed macaques. J Virol 70:3189-3197.
16. Joag SV, Li Z, Foresman L; Pinson DM, Raghavan R, Zhuge W, Adany I, Wang C, Jia F, Sheffer D, Ranchalis J, Watson A, Narayan O. 1997. Characterization of the pathogenic KU-SHIV model of acquired immunodeficiency syndrome in macaques. AIDS Res Hum Retroviruses 13:635-645.
17. +T cell loss and AIDS in rhesus macaques. J Med Primatol 27:59-64.
18. Kawamura M, Naitou T, Ueno M, Akagi T, Hiraishi K, Takai I, Makino M, Serizawa T, Sugimura K, Akashi M, Baba M. 2002. Induction of mucosal IgA following intravaginal administration of inactivated HIV-1-capturing nanospheres in mice. J Med Virol 66:291-298.
19. Kuwata T, Igarashi T, Ido E, Jin M, Mizuno A, Chen J, Hayami M. 1995. Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication. J Gen Virol 76:2181-2191.
20. Kuwata T, Miura T, Hayami M. 2001. Using SHIVs to develop an anti-HIV-1 live-attenuated vaccine. Trends Microbiol 9:475-480.
21. Lehner T, Anton PA. 2002. Mucosal immunity and vaccination against HIV. AIDS 16:S125-S132.
22. Lehner T, Wang Y, Cranage M, Bergmeier LA, Mitchell E, Tao L, Hall G, Dennis M, Cook N, Jones I, Doyle C. 1996. Protective mucosal immunity elicited by targeted lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat Med 2:767-775.
23. Li J, Lord CI, Haseltine W, Letvin NL, Sodroski J. 1992. Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins. J Acquir Immune Defic Syndr 5:639-646.
24. Lo Caputo S, Trabattoni D, Vichi F, Piconi S, Lopalco L, Villa ML, Mazzotta F, Clerici M. 2003. Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men. AIDS 17:531-539.
25. Lu Y, Brosio P, Lafaile M, Li J, Collman RG, Sedroski J, Miller CJ. 1996. Vaginal transmission of chimeric simian/human immunodeficiency viruses in rhesus macaques. J Virol 70:3045-3050.
26. Lu X, Kiyono H, Lu D, Kawabata S, Torten J, Srinivasan S, Dailey PJ, McGhee JR, Lehner T, Miller CJ. 1998. Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251. AIDS 12:1-10.
27. Marx PA, Compans RW, Gettie A, Staas JK, Gilley RM, Mulligan MJ, Yamshchikov GV, Chen D, Eldridge JH. 1993. Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260:1323-1327.
28. Mascola JR, Frankel SS, Broliden K. 2000a. HIV-1 entry at the mucosal surface: Role of antibodies in protection. AIDS 14:S167-S174.
29. Mascola JR, Stiegler G, VanCott TC, Katinger H, Carpenter CB, Hanson CE, Beary H, Hayes D, Frankel SS, Birx DL, Lewis MG. 2000b. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med 6:207-210.
30. Mazzoli S, Trabattoni D, Lo Caputo S, Piconi S, Ble C, Meacci F, Ruzzante S, Salvi A, Semplici F, Longhi R, Fusi ML, Tofani N, Biasin M, Villa ML, Mazzotta F, Clerici M. 1997. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med 3:1250-1257.
31. Mazzoli S, Lopalco L, Salvi A, Trabattoni D, Lo Caputo S, Semplici F, Biasin M, BlC, Cosma A, Pastori C, Meacci F, Mazzotta F, Villa ML, Siccardi AG, Clerici M. 1999. Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons. J Infect Dis 180:871-875.
32. Miller CJ, Hu J. 1999. T cell-tropic simian immunodeficiency virus (SIV) and simian-human immunodeficiency viruses are readily transmitted by vaginal inoculation of rhesus macaques, and Langerhans' cells of the female genital tract are infected with SIV. J Infect Dis 179:S413-S417.
33. Nardelli-Haefliger D, Roden R, Balmelli C, Potts A, Schiller J, De Grandi P. 1999. Mucosal but not parenteral immunization with purified human papillomavirus type 16 virus-like particles induces neutralizing titers of antibodies throughout the estrous cycle of mice. J Virol 73:9609-9613.
34. Polacino P, Stallard V, Montefiori DC, Brown CR, Richardson BA, Morton WR, Benveniste RE, Hu SL. 1999. Protection of macaques against intrarectal infection by a combination immunization regimen with recombinant simian immunodeficiency virus SIVmne gp160 vaccines. J Virol 73:3134-3146.
35. Reimann KA, Li JT, Voss G, Lekutis C, Tenner-Racz K, Racz P, Lin W, Montefiori DC, Lee-Parritz DE, Lu Y, Collman RG, Sodroski J, Letvin NL. 1996a. An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys. J Virol 70:3198-3206.
36. Reimann KA, Li JT, Veazey R, Halloran M, Park IW, Karlsson GB, Sodroski J, Letvin NL. 1996b. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J Virol 70:6922-6928.
37. Sakaue G, Hiroi T, Nakagawa Y, Someya K, Iwatani K, Sawa Y, Takahashi H, Honda M, Kunisawa J, Kiyono H. 2003. HIV mucosal vaccine: Nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses. J Immunol 170:495-502.
38. Shinohara K, Sakai K, Ando S, Ami Y, Yoshino N, Takahashi E, Someya K, Suzaki Y, Nakasone T, Sasaki Y, Kaizu M, Lu Y, Honda M. 1999. A highly pathogenic simian/human immunodeficiency virus with genetic changes in cynomolgus monkey. J Gen Virol 80:1231-1240.
39. Staats HF, Nichols WG, Palker TJ. 1996. Mucosal immunity to HIV-1: Systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide TlSP10 MN(A). J Immunol 157:462-472.
40. Staats HF, Montgomery SP, Palker TJ. 1997. Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses. AIDS Res Hum Retroviruses 13:945-952.
41. Suryanarayana K, Wiltrout TA, Vasquez GM, Hirsch VM, Lifson JD. 1998. Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction. AIDS Res Hum Retroviruses 14:183-189.
42. Ui M, Kuwata T, Igarashi T, Ibuki K, Miyazaki Y, Kozyrev IL, Enose Y, Shimada T, Uesaka H, Yamamoto H, Miura T, Hayami M. 1999. Protection of macaques against a SHIV with a homologous HIV-1 Env and a pathogenic SHIV-89.6P with a heterologous Env by vaccination with multiple gene-deleted SHIVs. Virology 265:252-263.
43. van Egmond M, Damen CA, van Spriel AB, Vidarsson G, van Garderen E, van de Winkel JG. 2001. IgA and the IgA Fc receptor. Trends Immunol 22:205-211.
44. Voss G, Manson K, Montefiori D, Watkins DI, Heeney J, Wyand M, Cohen J, Bruck C. 2003. Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine. J Virol 77:1049-1058.
45. Zuercher AW, Coffin SE, Thurnheer MC, Fundova P, Cebra JJ. 2002. Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses. J Immunol 168:1796-1803.